Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model

See allHide authors and affiliations

Science  16 Jan 1998:
Vol. 279, Issue 5349, pp. 377-380
DOI: 10.1126/science.279.5349.377

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


In vivo selection of phage display libraries was used to isolate peptides that home specifically to tumor blood vessels. When coupled to the anticancer drug doxorubicin, two of these peptides—one containing an αv integrin–binding Arg-Gly-Asp motif and the other an Asn-Gly-Arg motif—enhanced the efficacy of the drug against human breast cancer xenografts in nude mice and also reduced its toxicity. These results indicate that it may be possible to develop targeted chemotherapy strategies that are based on selective expression of receptors in tumor vasculature.

  • * These authors contributed equally to this report.

  • To whom correspondence should be addressed. E-mail: ruoslahti{at}

View Full Text

Stay Connected to Science